These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31497356)

  • 1. Natural killer cell-based adoptive transfer immunotherapy for pancreatic ductal adenocarcinoma in a
    Hu S; Yang J; Shangguan J; Eresen A; Li Y; Ma Q; Yaghmai V; Velichko Y; Hu C; Zhang Z
    Am J Cancer Res; 2019; 9(8):1757-1765. PubMed ID: 31497356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive dynamic monitoring initiation and growth of pancreatic tumor in the LSL-Kras
    Hu S; Pan L; Shangguan J; Figini M; Eresen A; Sun C; Wang B; Ma Q; Hu C; Yaghmai V; Velichko Y; Yang J; Zhang Z
    J Immunol Methods; 2019 Feb; 465():1-6. PubMed ID: 30468734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma.
    Yang J; Hu S; Shangguan J; Eresen A; Li Y; Pan L; Ma Q; Velichko Y; Wang J; Hu C; Yaghmai V; Zhang Z
    Am J Cancer Res; 2019; 9(11):2456-2468. PubMed ID: 31815046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy.
    Horvat NK; Karpovsky I; Phillips M; Wyatt MM; Hall MA; Herting CJ; Hammons J; Mahdi Z; Moffitt RA; Paulos CM; Lesinski GB
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38191243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dinaciclib prolongs survival in the
    Yang J; Hu S; Shangguan J; Eresen A; Li Y; Ma Q; Yaghmai V; Benson Iii AB; Zhang Z
    Am J Transl Res; 2020; 12(3):1031-1043. PubMed ID: 32269732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Black raspberries suppress pancreatic cancer through modulation of NKp46
    Pan P; Zhu Z; Oshima K; Aldakkak M; Tsai S; Huang YW; Dong W; Zhang J; Lin CW; Wang Y; Yearsley M; Yu J; Wang LS
    Food Front; 2020 Mar; 1(1):70-82. PubMed ID: 32368735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.
    Fendrich V; Sparn M; Lauth M; Knoop R; Plassmeier L; Bartsch DK; Waldmann J
    Pancreatology; 2013; 13(5):502-7. PubMed ID: 24075515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma.
    Eresen A; Yang J; Shangguan J; Li Y; Hu S; Sun C; Velichko Y; Yaghmai V; Benson AB; Zhang Z
    J Transl Med; 2020 Feb; 18(1):61. PubMed ID: 32039734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of neuropeptide Y and its receptors Y1 and Y2 in pancreatic intraepithelial neoplasia and invasive pancreatic cancer in a transgenic mouse model and human samples of pancreatic cancer.
    Waldmann J; Fendrich V; Reichert M; Hecker A; Bartsch DK; Padberg W; Holler JPN
    J Surg Res; 2018 Mar; 223():230-236. PubMed ID: 29433879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancer.
    D'Alincourt Salazar M; Manuel ER; Tsai W; D'Apuzzo M; Goldstein L; Blazar BR; Diamond DJ
    Oncoimmunology; 2016 Jun; 5(6):e1160184. PubMed ID: 27471630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
    Mace TA; Shakya R; Pitarresi JR; Swanson B; McQuinn CW; Loftus S; Nordquist E; Cruz-Monserrate Z; Yu L; Young G; Zhong X; Zimmers TA; Ostrowski MC; Ludwig T; Bloomston M; Bekaii-Saab T; Lesinski GB
    Gut; 2018 Feb; 67(2):320-332. PubMed ID: 27797936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In Vivo.
    Li J; Qian W; Qin T; Xiao Y; Cheng L; Cao J; Chen X; Ma Q; Wu Z
    Comput Struct Biotechnol J; 2019; 17():498-506. PubMed ID: 31011408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.
    Lee JW; Komar CA; Bengsch F; Graham K; Beatty GL
    Curr Protoc Pharmacol; 2016 Jun; 73():14.39.1-14.39.20. PubMed ID: 27248578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer.
    Yang J; Eresen A; Shangguan J; Ma Q; Yaghmai V; Zhang Z
    Oncoimmunology; 2021 Feb; 10(1):1875638. PubMed ID: 33643692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry.
    An X; Ouyang X; Zhang H; Li T; Huang YY; Li Z; Zhou D; Li QX
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30371656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging biomarkers for pulsed focused ultrasound treatment of pancreatic ductal adenocarcinoma.
    Maloney E; Wang YN; Vohra R; Son H; Whang S; Khokhlova T; Park J; Gravelle K; Totten S; Hwang JH; Lee D
    World J Gastroenterol; 2020 Mar; 26(9):904-917. PubMed ID: 32206002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy.
    Torres MP; Rachagani S; Souchek JJ; Mallya K; Johansson SL; Batra SK
    PLoS One; 2013; 8(11):e80580. PubMed ID: 24278292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
    Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
    Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.